Rating History for Affimed Therapeutics (AFMD) by Cantor Fitzgerald

More Stocks Rated by Cantor Fitzgerald | Latest Ratings for AFMD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/14/2025 Li Watsek Downgrade Neutral
(Overweight)		 N/A
(N/A)		 0.13
(0.18)		 38.46% Details